EHR Data Support Reported Effectiveness of Ad26.COV2.S Vaccine
Vaccination was associated with a 3.73-fold reduction in SARS-CoV-2 infections.
Diagnosis & Disease Information
COVID-19 Vaccines Deemed Safe for Renal Cell Carcinoma Patients on Immune Checkpoint Inhibitors
The rate of new or worsening immune-related adverse events was no higher than previously reported.
COVID-19 Vaccination Yields High Seroconversion Rate in Renal Cell Carcinoma
The seroconversion rate was 92%.
Fully Vaccinated With Breakthrough Infection Can Transmit COVID-19
The peak viral load was similar for fully vaccinated and unvaccinated index cases.
COVID-19 Vaccine-Induced Immunity More Protective Than Infection
The risk of COVID-19 is more than 5-fold higher for unvaccinated patients with previous SARS-CoV-2 infection.
FDA Approves Pfizer COVID-19 Vaccine for Children Aged 5 to 11
Children ages 5 to 11 years can now receive one-third of the adult dose, with 2 injections given 3 weeks apart.
Lymphadenopathy After COVID-19 Vaccination More Common With Moderna Vaccine
Lymphadenopathy was seen more often in women than in men.
Non-COVID-19 Mortality Not Increased After COVID-19 Vaccination
There was no increased risk of non-COVID-19 mortality in recipients of the Pfizer, Moderna, or Janssen vaccines.
BNT162b2 Effectively Prevents Pediatric COVID-19 Hospitalization
Two doses of the Pfizer-BioNTech vaccine can prevent hospitalization in children aged 12 to 18 years.
CDC: Booster Recommendations Expanded to All Authorized COVID-19 Vaccines
The CDC recommendations also allow for the use of a heterologous (or “mix and match”) booster dose.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...